Home › Funds › Deep Track Capital, LP › AXSM

Deep Track Capital, LP position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

Deep Track Capital, LP reported holding 700,000 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$171.3M, representing 2.55% of its reported portfolio and ranking #18 among its reported holdings. Deep Track Capital, LP has disclosed AXSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)700.00K sh
Reported value held$171.34M
Portfolio Weight2.55%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's AXSM position evolved

Deep Track Capital, LP first disclosed a stake in AXSM in Q3 2023 at 1,140,745 shares (US$79.7M). The position peaked in Q4 2025 at 1,150,000 shares, worth US$210.0M. Across 10 filings, Deep Track Capital, LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$171.3M — a reduction of -400,000 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2024 (shares rose 12% over the following quarter), a 89% trim in Q3 2024 (shares fell 6% over the following quarter), a 36% trim in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.14M $79.73M New
Q4 2023 1.00M $79.59M Reduce
Q1 2024 1.30M $104.12M Add
Q2 2024 1.85M $149.15M Add
Q3 2024 200.00K $17.97M Reduce
Q2 2025 801.37K $83.66M New
Q3 2025 900.00K $109.31M Add
Q4 2025 1.15M $210.04M Add
Q1 2026 1.10M $185.92M Reduce
Q2 2026 700.00K $171.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 53 other funds we track also report a position in AXSM — the largest reported positions include ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$77.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has Deep Track Capital, LP held AXSM?

Deep Track Capital, LP has disclosed AXSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Deep Track Capital, LP's current position in AXSM?

As of Q2 2026, Deep Track Capital, LP holds 700.00K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $171.34M, representing 2.55% of its reported portfolio and ranking #18.

Has Deep Track Capital, LP been buying or selling AXSM?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP reduced its position in AXSM. The position peaked in Q4 2025 at 1.15M shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, EVENTIDE ASSET MANAGEMENT, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.